Efficacy of Anti-Fungal Agents Incorporated in Tissue Conditioners in Inhibiting the Growth of Candida albicans

被引:0
|
作者
Bhat, Vidya S. [1 ]
Bhat, Varsha P. [1 ]
Agarwal, Anurag [1 ]
Shetty, Sanath [1 ]
机构
[1] Yenepoya Dent Coll, Dept Prosthodont, Mangaluru, Karnataka, India
关键词
Anti-Fungal; Tissue Conditioner; Chronic Atrophic Candidiasis; STOMATITIS; INVITRO;
D O I
10.14260/jemds/2020/856
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Chronic atrophic candidiasis is an inflammation of the oral cavity. Because of the diverse possible origins of denture stomatitis, several treatment procedures are used, like antifungal therapy, correction of ill-fitting dentures and effective plaque control. Tissue conditioners (porous in nature, tend to harbor bacteria) have been used to enhance adaptation of the removable denture prosthesis and aid in recovery of denture bearing tissues. A lot of complete denture wearers, owing to their age, lack the manual dexterity to maintain adequate denture hygiene. Incorporating antifungal agents in tissue conditioners may be a useful method of drug delivery to overcome the above-mentioned obstacles for effective treatment. This in vitro study tests the efficacy of 2 antifungal drugs, fluconazole and ketoconazole incorporated in 2 tissue conditioners (Viscogel and GC Soft) in inhibiting the growth of Candida albicans. METHODS This is an experimental study of two antifungal agents (fluconazole and ketoconazole) in powdered form which were incorporated into powder of the tissue conditioner in a specific concentration and tested against a culture of Candida albicans. The mixed tissue conditioner was injected into 6 mm diameter holes, punched in the plates of the culture medium. Then the plates were incubated and the inhibition diameter for each sample was measured after 24 hrs. Readings were subjected to statistical analysis. RESULTS Controls did not show any zone of inhibition. GC Soft with ketoconazole combination had a mean of 27.97 mm; GC Soft with fluconazole showed a mean of 25.97. The combination of Viscogel with ketoconazole showed a mean diameter of inhibition of 26.07 mm; the combination of Viscogel and fluconazole showed a mean of 27.33 mm and was non-significant. CONCLUSIONS There was no inhibition of Candida albicans observed in Viscogel and GC Soft controls. The antifungal agents ketoconazole and fluconazole combined with Viscogel and GC soft showed definite zone of inhibition indicating positive inhibitory effect on Candida albicans.
引用
收藏
页码:3904 / 3908
页数:5
相关论文
共 50 条
  • [31] ANTI-FUNGAL AGENTS USEFUL IN THERAPY OF SYSTEMIC FUNGAL-INFECTIONS
    MEDOFF, G
    BRAJTBURG, J
    KOBAYASHI, GS
    BOLARD, J
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1983, 23 : 303 - 330
  • [32] SAR of novel anti-fungal agents targeting the synthesis of fungal GlcCer
    Haranahalli, Krupanandan
    Lazzarini, Cristina
    Sun, Yi
    Del Poeta, Maurizio
    Ojima, Iwao
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [33] Recent advances in topical carriers of anti-fungal agents
    Garg, Abhinava
    Sharma, Ganti S.
    Goyal, Amit K.
    Ghosh, Goutam
    Si, Sudam Chandra
    Rath, Goutam
    HELIYON, 2020, 6 (08)
  • [34] Pleurotus sajor-caju can be used to synthesize silver nanoparticles with anti-fungal activity against Candida albicans
    Sandai, D.
    Tabana, Y.
    Musa, F.
    MEDICAL MYCOLOGY, 2018, 56 : S35 - S35
  • [35] Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
    Bacher, Petra
    Hohnstein, Thordis
    Beerbaum, Eva
    Roecker, Marie
    Blango, Matthew G.
    Kaufmann, Svenja
    Roehmel, Jobst
    Eschenhagen, Patience
    Grehn, Claudia
    Seidel, Kathrin
    Rickerts, Volker
    Lozza, Laura
    Stervbo, Ulrik
    Nienen, Mikalai
    Babel, Nina
    Milleck, Julia
    Assenmacher, Mario
    Cornely, Oliver A.
    Ziegler, Maren
    Wisplinghoff, Hilmar
    Heine, Guido
    Worm, Margitta
    Siegmund, Britta
    Maul, Jochen
    Creutz, Petra
    Tabeling, Christoph
    Ruwwe-Gloesenkamp, Christoph
    Sander, Leif E.
    Knosalla, Christoph
    Brunke, Sascha
    Hube, Bernhard
    Kniemeyer, Olaf
    Brakhage, Axel A.
    Schwarz, Carsten
    Scheffold, Alexander
    CELL, 2019, 176 (06) : 1340 - +
  • [36] AN EVALUATION OF THE ANTI-FUNGAL EFFECT OF BIFONAZOLE ON TORULOPSIS GLABRATA AND CANDIDA-ALBICANS UNDER VARIOUS INVITRO TEST CONDITIONS
    BARUG, D
    BASTIAANSE, HB
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1983, 33-1 (04): : 524 - 528
  • [37] CONJUNCTIVA CONTAINS FACTOR INHIBITING GROWTH OF CANDIDA ALBICANS
    KOZINN, PJ
    TASCHDJIAN, CL
    CAROLINE, L
    SCIENCE, 1964, 146 (365) : 1479 - &
  • [38] RETRACTED: Anti-fungal efficacy of Miswak Extract (Salvadora Persica) and commercial cleaner against Candida albicans on heat cured polymethylmethacrylate denture base (Retracted Article)
    Wajdan, Nadia
    Aslam, Kashif
    Amin, Rafat
    Khan, Sadaf
    Ahmed, Naseer
    Lal, Abhishek
    AlHamdan, Eman M.
    Vohra, Fahim
    Abduljabbar, Tariq
    Heboyan, Artak
    JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS, 2023, 21
  • [39] Synthesis of aromatic glycoconjugates as anti-fungal agents against Candida spp. and assessment of their covalent crosslinking capabilities
    Doherty, Kyle
    Kessie, Keela
    Martin, Harlei
    Loughlin, Jordan
    Dulawa, Oliwier
    Kasements, Kaja
    Velasco-Torrijos, Trinidad
    BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 117
  • [40] SAR study of novel anti-fungal agents targeting the synthesis of fungal sphingolipids
    Raghunandan, Krupanandan
    Hu, Kongzhen
    Lazzarini, Cristina
    DelPoeta, Maurizio
    Ojima, Iwao
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252